Vienna - Delayed Quote EUR

Avantor, Inc. (AVTR.VI)

Compare
21.20 -0.40 (-1.85%)
At close: December 13 at 5:32:06 PM GMT+1
Loading Chart for AVTR.VI
DELL
  • Previous Close 21.60
  • Open 21.60
  • Bid --
  • Ask 21.20 x --
  • Day's Range 21.20 - 21.60
  • 52 Week Range 18.70 - 25.60
  • Volume 0
  • Avg. Volume 12
  • Market Cap (intraday) 14.512B
  • Beta (5Y Monthly) 1.35
  • PE Ratio (TTM) 49.30
  • EPS (TTM) 0.43
  • Earnings Date Feb 12, 2025 - Feb 17, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

www.avantorsciences.com

14,500

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AVTR.VI

View More

Performance Overview: AVTR.VI

Trailing total returns as of 12/13/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

AVTR.VI
1.15%
S&P 500
26.86%

1-Year Return

AVTR.VI
8.68%
S&P 500
30.31%

3-Year Return

AVTR.VI
39.43%
S&P 500
28.42%

5-Year Return

AVTR.VI
26.95%
S&P 500
90.97%

Compare To: AVTR.VI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AVTR.VI

View More

Valuation Measures

Annual
As of 12/13/2024
  • Market Cap

    14.51B

  • Enterprise Value

    18.94B

  • Trailing P/E

    49.49

  • Forward P/E

    19.72

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.23

  • Price/Book (mrq)

    2.73

  • Enterprise Value/Revenue

    2.91

  • Enterprise Value/EBITDA

    19.19

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.54%

  • Return on Assets (ttm)

    3.27%

  • Return on Equity (ttm)

    5.81%

  • Revenue (ttm)

    6.82B

  • Net Income Avi to Common (ttm)

    309.6M

  • Diluted EPS (ttm)

    0.43

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    285.3M

  • Total Debt/Equity (mrq)

    88.62%

  • Levered Free Cash Flow (ttm)

    658.37M

Research Analysis: AVTR.VI

View More

Company Insights: AVTR.VI

Research Reports: AVTR.VI

View More